文献速递胰腺与胆道疾病消化内镜

超声内镜引导下胆囊引流采用管腔贴合金属支架与经皮经肝胆囊引流治疗急性胆囊炎的疗效相似

Similar Efficacies of Endoscopic Ultrasound Gallbladder Drainage With a Lumen-Apposing Metal Stent Versus Percutaneous Transhepatic Gallbladder Drainage for Acute Cholecystitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2016-12-30

这项回顾性多中心研究比较了超声内镜引导下胆囊引流(EUS-GBD)与经皮经肝胆囊引流(PT-GBD)治疗不适合手术的急性胆囊炎患者,EUS-GBD组45例、PT-GBD组45例。两组技术成功率和临床成功率相似,EUS-GBD组术后疼痛评分更低、住院时间更短、重复干预次数更少,不良事件有减少趋势但未达统计学显著。

要点

  • EUS-GBD与PT-GBD技术成功率98% vs 100%(P=.88)、临床成功率96% vs 91%(P=.20),均无显著差异。
  • EUS-GBD组术后平均疼痛评分2.5 vs PT-GBD组6.5(P<.05),住院时间3天 vs 9天(P<.05)。
  • EUS-GBD组重复干预11次 vs PT-GBD组112次(P<.05),人均重复干预0.2±0.4 vs 2.5±2.8(P<.05)。

核心结论

  • EUS-GBD与PT-GBD的技术成功率和临床成功率相似,对于不适合手术的患者,EUS-GBD应被考虑作为替代选择。
  • 接受EUS-GBD的患者似乎住院时间更短、疼痛评分更低、重复干预更少,不良事件有减少趋势。
  • 作者认为需要前瞻性对照研究来证实这些结果。

研究设计与样本

  • 回顾性研究,比较EUS-GBD与PT-GBD,纳入7个中心(美国5个、欧洲1个、亚洲1个),时间范围为2013年至2015年。
  • 共纳入90例不适合手术的急性胆囊炎患者(56例男性;61例结石性、29例非结石性),EUS-GBD组45例、PT-GBD组45例。

主要发现

  • 技术成功率EUS-GBD组98% vs PT-GBD组100%(P=.88),临床成功率EUS-GBD组96% vs PT-GBD组91%(P=.20)。
  • 不良事件EUS-GBD组5例(11%)vs PT-GBD组14例(32%)(P=.065),严重程度分布无显著差异:轻度2 vs 5(P=.27)、中度4 vs 3(P=.98)、重度1 vs 3(P=.62)、死亡1 vs 3(P=.61)。
  • 术后平均疼痛评分EUS-GBD组2.5 vs PT-GBD组6.5(P<.05),EUS-GBD组更低。
  • 平均住院时间EUS-GBD组3天 vs PT-GBD组9天(P<.05),EUS-GBD组更短;重复干预次数EUS-GBD组11次 vs PT-GBD组112次(P<.05),人均重复干预EUS-GBD组0.2±0.4 vs PT-GBD组2.5±2.8(P<.05)。
  • 引流后中位随访时间EUS-GBD组215天(范围1-621天)vs PT-GBD组265天(范围1-1638天)。

关键数值与推荐

  • 临床成功定义为干预后3天内症状或实验室和/或影像学异常缓解。
  • 不良事件按美国胃肠内镜学会定义分级。
  • EUS-GBD组中30例使用非电灼LAMS、15例使用电灼增强LAMS。

临床怎么用

  • 对于不适合手术的急性胆囊炎患者,EUS-GBD可考虑作为PT-GBD的替代选择。
  • 接受EUS-GBD的患者似乎住院时间更短、疼痛评分更低、重复干预更少。

局限性

  • 原文为回顾性研究。
  • 作者认为需要前瞻性对照研究来证实这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute cholecystitis in patients who are not candidates for surgery is often managed with percutaneous transhepatic gallbladder drainage (PT-GBD). Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) with a lumen-apposing metal stent (LAMS) is an effective alternative to PT-GBD. We compared the technical success of EUS-GBD versus PT-GBD, and patient outcomes, numbers of adverse events (AEs), length of hospital stay, pain scores, and repeat interventions. METHODS: We performed a retrospective study to compare EUS-GBD versus PT-GBD at 7 centers (5 in the United States, 1 in Europe, and 1 in Asia), from 2013 through 2015, in management of acute cholecystitis in patients who are not candidates for surgery. A total of 90 patients (56 men) with acute cholecystitis (61 calculous, 29 acalculous) underwent EUS-GBD (n = 45) or PT-GBD (n = 45). Data were collected on technical success, clinical success (resolution of symptoms or laboratory and/or radiologic abnormalities within 3 days of intervention), and need for repeat intervention. Characteristics were compared using Student t tests for continuous variables and the chi-square test, or the Fisher exact test, when appropriate, for categorical variables. Adverse events were graded according to American Society for Gastrointestinal Endoscopy definitions and compared using the Fisher exact test. Postprocedure pain scores were compared using the Mann-Whitney U test. RESULTS: Baseline characteristics, type, and clinical severity of cholecystitis were comparable between groups. In the EUS-GBD group, noncautery LAMS were used in 30 patients and cautery-enhanced LAMS were used in 15. Technical success was achieved for 98% of patients in the EUS-GBD and 100% of the patients in the PT-GBD group (P = .88). Clinical success was achieved by 96% of patients in the EUS-GBD group and 91% in the PT-GBD group (P = .20). There was a nonsignificant trend toward fewer AEs in the EUS-GBD group (5 patients; 11%) than in the PT-GBD group (14 patients; 32%) (P = .065). There were no significant differences in the severity of the AEs: mild, 2 in the EUS-GBD group versus 5 in the PT-GBD group (P = .27); moderate, 4 versus 3 (P = .98); severe, 1 versus 3 (P = .62); or deaths, 1 versus 3 (P = .61). The mean postprocedure pain score was lower in the EUS-GBD group than in the PT-GBD group (2.5 vs 6.5; P < .05). The EUS-GBD group had a shorter average length of stay in the hospital (3 days) than the PT-GBD group (9 days) (P < .05) and fewer repeat interventions (11 vs 112) (P < .05). The average number of repeat interventions per patients was 0.2 ± 0.4 EUS-GBD group versus 2.5 ± 2.8 in the PT-GBD group (P < .05). Median follow-up after drainage was comparable in EUS-GBD group (215 days; range, 1-621 days) versus the PT-GBD group (265 days; range, 1-1638 days). CONCLUSIONS: EUS-GBD has similar technical and clinical success compared with PT-GBD and should be considered an alternative for patients who are not candidates for surgery. Patients who undergo EUS-GBD seem to have shorter hospital stays, lower pain scores, and fewer repeated interventions, with a trend toward fewer AEs. A prospective, comparative study is needed to confirm these results.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Irani S, Ngamruengphong S, Teoh A, et al. Similar Efficacies of Endoscopic Ultrasound Gallbladder Drainage With a Lumen-Apposing Metal Stent Versus Percutaneous Transhepatic Gallbladder Drainage for Acute Cholecystitis. Clin Gastroenterol Hepatol. 2016. PMID: 28043931. doi:10.1016/j.cgh.2016.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。